Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Comment by PTBaileyon Oct 21, 2021 6:20am
77 Views
Post# 34031211

RE:RE:Re: Back Up !!!

RE:RE:Re: Back Up !!!
HighSkies2019 wrote: Bud....your melting ice cream and your nice fresh pie that's turning sour ....well ... that's not the only thing melting and turning sour....trying my best to keep fresh.... though I held off on the booze cruise ... gonna need something soon either to drown the sorrows or forget the sorrow .... looks like whoever is playing the order book is trying to close at 0.25 .... so will hang on for another day.... come on Uncle Bobby get with the game... glta


Think I will leave my pie in the freezer for a bit.

I was expecting a decent jump in the SP after the finances were announced but we still haven't done or started anything even though now we hve the funding. I am wondering if SP is a reflection of low investor confidence due to the history of delays, ups and downs and disappointments. 

I stil say we need to get off the launching pad of phase 1 and get this thing started. Comany needs to regain investor confidence and ride the momentum of future positive announcements. Doing so will take time as it takes more effor to regain confidence then to maintain it in the first place. It may take being well into phase 1 or a successful finish to regain that confidence. 

Phase 1 is coming and along with that whatever else Bob has that he is working on that none of us know about. Can't believe he is just sitting around waiting for phase 1 to be completed before he attempts to make any deals for licensing. I am in for the long haul so right now I don't like the price but I am also no where near prepared to start selling shares. 

For people who want to make quick money and flip shares this isn't the stock. I will be happy if I can make some decent money by taking some shares off the table within the next two years.

So long term how much difference or impact will todays SP have? When phase 1 & 2 are completed and a few potential deals are announced within the next year how likely are we to be still stressing over a 25cent stock? And if things go as we hope and expect the Bob bashers will become fans.
<< Previous
Bullboard Posts
Next >>